BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Endocrine gland cancer AND CD274, PDL1, 29126, ENSG00000120217, PDCD1L1, PD-L1, MGC142296, PDCD1LG1, MGC142294, B7H1, Q9NZQ7, B7-H AND Prognosis
270 results:

  • 1. Genomic landscape and distinct molecular subtypes of primary testicular lymphoma.
    Zhang W; Yang P; Yang Y; Liu S; Xu Y; Wu C; Wang J; Liu C; Liu H; Li S; Huang W; Jing H
    J Transl Med; 2024 May; 22(1):414. PubMed ID: 38693538
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. A novel TCGA-validated programmed cell-death-related signature of ovarian cancer.
    Cai X; Lin J; Liu L; Zheng J; Liu Q; Ji L; Sun Y
    BMC Cancer; 2024 Apr; 24(1):515. PubMed ID: 38654239
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Undifferentiated Carcinoma with Osteoclast-like Giant Cells of the Pancreas: Molecular Genetic Analysis of 13 Cases.
    Hrudka J; Kalinová M; Ciprová V; Moravcová J; Dvořák R; Matěj R
    Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542259
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Chronic Lymphocytic Thyroiditis with Oncocytic Metaplasia Influences pd-l1 Expression in Papillary Thyroid Carcinoma.
    Santana VB; Krüger VM; Abrahão MCY; Cantú PLM; Brackmann RL; Pandolfi GM; Marisco LS; Remonatto G; Ferreira LA; Graudenz MS
    Head Neck Pathol; 2024 Mar; 18(1):14. PubMed ID: 38457034
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Targeting Tryptophan Catabolism in Ovarian cancer to Attenuate Macrophage Infiltration and pd-l1 Expression.
    Crump LS; Floyd JL; Kuo LW; Post MD; Bickerdike M; O'Neill K; Sompel K; Jordan KR; Corr BR; Marjon N; Woodruff ER; Richer JK; Bitler BG
    Cancer Res Commun; 2024 Mar; 4(3):822-833. PubMed ID: 38451784
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. 4-Hydroxyphenylpyruvate Dioxygenase-Like predicts the prognosis and the immunotherapy response of cancers: a pan-cancer analysis.
    Li H; Liu J; Wang S; Xu Y; Tang Q; Ying G
    Aging (Albany NY); 2024 Mar; 16(5):4327-4347. PubMed ID: 38451188
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. A new era of immune therapeutics for pancreatic cancer: Monoclonal antibodies paving the way.
    Balar PC; Apostolopoulos V; Chavda VP
    Eur J Pharmacol; 2024 Apr; 969():176451. PubMed ID: 38408598
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. An exosome-derived lncRNA signature identified by machine learning associated with prognosis and biomarkers for immunotherapy in ovarian cancer.
    Cui Y; Zhang W; Lu W; Feng Y; Wu X; Zhuo Z; Zhang D; Zhang Y
    Front Immunol; 2024; 15():1228235. PubMed ID: 38404588
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Periostin is associated with prognosis and immune cell infiltration in pancreatic adenocarcinoma based on integrated bioinformatics analysis.
    Chen Y; Zhang F; Zhang B; Trojanowicz B; Hämmerle M; Kleeff J; Sunami Y
    Cancer Rep (Hoboken); 2024 Feb; 7(2):e1990. PubMed ID: 38389400
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. CD47-a novel prognostic predicator in epithelial ovarian cancer and correlations with clinicopathological and gene mutation features.
    Luo X; Mo J; Zhang M; Huang W; Bao Y; Zou R; Yao L; Yuan L
    World J Surg Oncol; 2024 Feb; 22(1):44. PubMed ID: 38317230
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Construction and validation of molecular subtype and signature of immune cell-related telomeric genes and prediction of prognosis and immunotherapy efficacy in ovarian cancer patients.
    Ling L; Li B; Wu H; Zhang K; Li S; Ke B; Zhu Z; Liu T; Liu P; Zhang B
    J Gene Med; 2024 Jan; 26(1):e3606. PubMed ID: 38282157
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Characteristics and immune checkpoint status of radioiodine-refractory recurrent papillary thyroid carcinomas from Ukrainian Chornobyl Tissue Bank donors.
    Bogdanova T; Rogounovitch TI; Zurnadzhy L; Mitsutake N; Tronko M; Ito M; Bolgov M; Chernyshov S; Gulevatyi S; Masiuk S; Yamashita S; Saenko VA
    Front Endocrinol (Lausanne); 2023; 14():1343848. PubMed ID: 38260161
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Integration of scRNA and bulk RNA-sequence to construct the 5-gene molecular prognostic model based on the heterogeneity of thyroid carcinoma endothelial cell.
    Ni Z; Cong S; Li H; Liu J; Zhang Q; Wei C; Pan G; He H; Liu W; Mao A
    Acta Biochim Biophys Sin (Shanghai); 2024 Feb; 56(2):255-269. PubMed ID: 38186223
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Pancancer analysis uncovers an immunological role and prognostic value of the m6A reader IGF2BP2 in pancreatic cancer.
    Deng H; Yao H; Zhou S; He C; Huang Y; Li Y; Chen H; Shu J
    Mol Cell Probes; 2024 Feb; 73():101948. PubMed ID: 38122949
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Advances in understanding and management of high-grade pancreatic neuroendocrine neoplasm: a comprehensive review.
    Regalla DKR; Deep O; Paluri RK
    Chin Clin Oncol; 2023 Dec; 12(6):67. PubMed ID: 38073310
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Inhibition of SF3B1 improves the immune microenvironment through pyroptosis and synergizes with αpdl1 in ovarian cancer.
    Wang S; Liu Y; Xiao H; Chen Z; Yang X; Yin J; Li Y; Yuan C; Yan S; Chen G; Gao Q; Kong B; Sun C; Song K
    Cell Death Dis; 2023 Nov; 14(11):775. PubMed ID: 38012150
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Prognostic significance of pd-l1 expression in pancreatic cancer: evidence from an updated meta-analysis.
    Liu C; Fan L; Wu Q; Shi Y; Sun X
    Pol J Pathol; 2023; 74(3):151-160. PubMed ID: 37955534
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Expression of EGFR, pd-l1, and the mismatch repair proteins before and following therapy in malignant serous effusions with metastatic high-grade serous tubo-ovarian carcinoma.
    Nikas IP; Park SY; Song MJ; Lee C; Ryu HS
    Diagn Cytopathol; 2024 Feb; 52(2):69-75. PubMed ID: 37937321
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. pd-l1 Expression and Ultrasound Characteristics in Papillary Thyroid Carcinoma and Its Effect on Recurrence.
    Li R; Li M; Sun B; Qi M; Peng C; Li H; Zheng S; Liu Q; Jiang C
    In Vivo; 2023; 37(6):2820-2828. PubMed ID: 37905619
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. High expression ITGA2 affects the expression of MET, pd-l1, CD4 and CD8 with the immune microenvironment in pancreatic cancer patients.
    Jin L; Duan Y; Li X; Li Z; Hu J; Shi H; Su Z; Li Z; Du B; Chen Y; Tan Y
    Front Immunol; 2023; 14():1209367. PubMed ID: 37881431
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 14.